CSS
RCKT icon

Cubist Systematic Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History

Cubist Systematic Strategies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-718,781
Closed -$1.76M – 3456
2025
Q2 		$1.76M Buy
+718,781
New +$3.64M 0.01% 1621
2025
Q1 		– Sell
-28,441
Closed -$357K – 3403
2024
Q4 		$357K Buy
+28,441
New +$428K ﹤0.01% 2326
2024
Q1 		– Sell
-7,319
Closed -$219K – 4177
2023
Q4 		$219K Buy
+7,319
New +$162K ﹤0.01% 2954
2022
Q4 		– Sell
-157,109
Closed -$2.51M – 4534
2022
Q3 		$2.51M Buy
+157,109
New +$2.45M 0.01% 1772
2022
Q2 		– Sell
-34,452
Closed -$546K – 4526
2022
Q1 		$546K Sell
34,452
-18,558
-35% -$321K ﹤0.01% 2485
2021
Q4 		$1.16M Buy
53,010
+51,210
+2,845% +$1.4M 0.01% 1809
2021
Q3 		$54K Sell
1,800
-5,162
-74% -$188K ﹤0.01% 2827
2021
Q2 		$308K Sell
6,962
-13,651
-66% -$593K ﹤0.01% 2314
2021
Q1 		$915K Buy
+20,613
New +$1.13M 0.01% 1593
2020
Q3 		– Sell
-9,261
Closed -$194K – 2610
2020
Q2 		$194K Buy
+9,261
New +$167K ﹤0.01% 2046
2020
Q1 		– Sell
-22,525
Closed -$513K – 2392
2019
Q4 		$513K Buy
+22,525
New +$376K 0.01% 1541
2017
Q1 		– Sell
-326
Closed -$8K – 1812
2016
Q4 		$8K Buy
326
+151
+86% +$4.31K ﹤0.01% 1661
2016
Q3 		$7K Hold
175
– – ﹤0.01% 1648
2016
Q2 		$5K Hold
175
– – ﹤0.01% 1670
2016
Q1 		$5K Hold
175
– – ﹤0.01% 1567
2015
Q4 		$8K Sell
175
-55
-24% -$2.4K ﹤0.01% 1709
2015
Q3 		$9K Buy
+230
New +$10.6K ﹤0.01% 1810

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Cubist Systematic Strategies's RCKT Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 718,781 shares — an estimated $1.76M sold.

Cubist Systematic Strategies first reported a position in RCKT in Q3 2015 and held it in 17 quarters. The position peaked at $2.51M in Q3 2022. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 718,781 Rocket Pharmaceuticals shares in Q3 2025, an estimated $1.76M.
  • Cubist Systematic Strategies first reported a position in Rocket Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Cubist Systematic Strategies's Rocket Pharmaceuticals position peaked at $2.51M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.